Molly E. Neal

Molly E. Neal

Otolaryngology | Plastic Surgery
1500 E Medical Center Dr
Floor 1 Reception A
Ann Arbor, MI 48109

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Combined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer.

Combined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer.

Journal: JAMA otolaryngology-- head & neck surgery
Published: August 06, 2026

Rural-Urban disparities in head and neck cancer mortality in the United States: Subsite-Specific Trends, 2010-2024.

Rural-Urban disparities in head and neck cancer mortality in the United States: Subsite-Specific Trends, 2010-2024.

Journal: Oral oncology
Published: August 02, 2026

Association of Neighborhood Deprivation With Breslow Thickness in Head and Neck Cutaneous Melanoma.

Association of Neighborhood Deprivation With Breslow Thickness in Head and Neck Cutaneous Melanoma.

Journal: The Laryngoscope
Published: April 14, 2026

Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance.

Late Recurrences Beyond Five Years in Salivary Adenoid Cystic Carcinoma: Implications for Long-Term Surveillance.

Journal: OTO open
Published: February 28, 2026

UV1 plus pembrolizumab in recurrent and metastatic head and neck squamous cell carcinoma: safe, immunogenic, but lacking efficacy.

UV1 plus pembrolizumab in recurrent and metastatic head and neck squamous cell carcinoma: safe, immunogenic, but lacking efficacy.

Journal: Translational cancer research
Published: December 01, 2025

Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma.

Hypoxia and Oxidation Pathway Crosstalk in Head and Neck Squamous Cell Carcinoma.

Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: November 16, 2025

Validation of MyHPVscore: A High-Performance Human Papillomavirus Circulating Tumor DNA Laboratory-Developed Test.

Validation of MyHPVscore: A High-Performance Human Papillomavirus Circulating Tumor DNA Laboratory-Developed Test.

Journal: The Journal of molecular diagnostics : JMD
Published: October 17, 2025

In-office secondary tracheoesophageal puncture with immediate voicing in post-laryngectomy patients.

In-office secondary tracheoesophageal puncture with immediate voicing in post-laryngectomy patients.

Journal: Oral oncology
Published: October 17, 2025

Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.

Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.

Journal: Cell death discovery
Published: September 16, 2025

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.

CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.

Journal: Head & neck
Published: August 07, 2025

FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.

FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 07, 2025

Considerations and Cautions in Postoperative HPV Circulating Tumor DNA Kinetics.

Considerations and Cautions in Postoperative HPV Circulating Tumor DNA Kinetics.

Journal: JAMA otolaryngology-- head & neck surgery
Published: May 14, 2025
Showing 1-12 of 58

Last Updated: 09/26/2026